Stereotaxis
    Print Page  Close Window
S-1/A
STEREOTAXIS, INC. filed this Form S-1/A on 05/12/2004
Entire Document
 << Previous Page | Next Page >>
<PAGE>



                                  ATTACHMENT 1
                    DESCRIPTION OF ITEMS AND PRICING SCHEDULE

PRICING SCHEDULE


<Table>
<Caption>
STEREOTAXIS                                                          
ITEM NUMBER      REVISION            DESCRIPTION          QUARTER    VOLUME      UNIT PRICE
------------     --------      ----------------------     -------    -------     ----------
<S>              <C>           <C>                        <C>        <C>         <C>
635-003701-1        -          Assy, Permanent Magnet      Q4-03     [***]          [***]  
635-003701-1        -          Assy, Permanent Magnet      Q1-04     [***]          [***] 
635-003701-1        -          Assy, Permanent Magnet      Q2-04     [***]          [***]
635-003701-1        -          Assy, Permanent Magnet      Q3-04     [***]          [***]
635-003701-1        -          Assy, Permanent Magnet      Q4-04     [***]          [***]
</Table>


DELIVERY SCHEDULE FOR FIRST PURCHASE ORDER - Q4-03 & Q1-04


<Table>
<Caption>
QTY TO DELIVER       DELIVERY DATE      QTY TO DELIVER        DELIVERY DATE
--------------       -------------      --------------        -------------
<S>                  <C>                <C>                  <C> 
    [***]                [***]               [***]                [***]   
    [***]                [***]               [***]                [***]   
    [***]                [***]               [***]                [***]   
    [***]                [***]               [***]                [***]   
    [***]                [***]           
    [***]                [***]           
</Table>


The above "Description of Items and Pricing Schedule" is intended to portray a
schedule of Stereotaxis' intent of procurement and an integrated Magnetics
commitment to pricing based on that intent. Stereotaxis will place an original
Purchase Order for the Q4-03 and Q1-04 quantities and pricing for a total of
[***] magnets for a total price of [***]. As time passes and deliveries are
made, Stereotaxis intends to place additional purchase orders based on updated
forecasts and requirements, but specific purchase orders will be released to
firm those commitments. Stereotaxis will maintain purchase order commitments to
cover periods not less than the following:

Magnet material commitments for 5 months in the future and completed magnet
assembly commitments of 5 months in the future. For example when the delivery
date of the last magnet on purchase order is five (5) months away, Stereotaxis
will place a purchase order for additional magnet material to cover at least 1
more month worth of magnets. When the delivery date of the last magnet on
purchase order is three (3) months away, Stereotaxis will place a purchase order
for additional magnets to cover at least 1 more month worth of magnets. If
finished magnets are not ordered to consume the committed magnet material within
a period of four (4) months, Stereotaxis will pay for the committed material.

Stereotaxis may adjust the quantity of magnets on purchase order to correspond
to the requirements of sales orders. Deliveries may be delayed up to six (6)
months from the above schedule (i.e., deliveries could be rescheduled out
through [***]). Changes in delivery shall require a minimum of three (3) months
notice, Pricing of the magnets will correspond to the quarter in which they are
scheduled for delivery on the purchase order, provided that the quantities
ordered are within 20% of the quantities forecasted. Magnets that are scheduled
for delivery in 2005 shall be priced at the Q4-04 price in the table above.

CREDITS

Stereotaxis shall receive a credit of [***] for each complete magnet crate that
is returned to Supplier. Partial magnet crates shall be saved until a complete
crate can be assembled, at which time Stereotaxis shall receive the [***]
credit.


[*** Indicates portions of this exhibit that have been omitted and filed
separately with the Securities and Exchange Commission pursuant to a request for
confidential treatment.]


                                    Page 12

 << Previous Page | Next Page >>